Contents

Current Cancer Drug Targets, Volume 4 - Number 7

Extracellular Tropomyosin: A Novel Common Pathway Target for Anti- Angiogenic Therapy

, 4(7): 543 - 553

Fernando Donate, Keith McCrae, David E. Shaw and Andrew P. Mazar


DOI: 10.2174/1568009043332781




Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy

, 4(7): 555 - 567

Hitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi and Hiroshi Fukui


DOI: 10.2174/1568009043332790




Targeting Apoptosis Pathways in Cancer Therapy

, 4(7): 569 - 576

Simone Fulda and Klaus-Michael Debatin


DOI: 10.2174/1568009043332763




Chemotherapeutic Agents That Induce Mitochondrial Apoptosis

, 4(7): 577 - 590

Tadashi Asakura and Kiyoshi Ohkawa


DOI: 10.2174/1568009043332772




Proline-Directed Protein Kinase FA as a Potential Target for Diagnosis and Therapy of Human Cancers

, 4(7): 591 - 596

Shiaw-Der Yang


DOI: 10.2174/1568009043332817




Alphaviruses and their Derived Vectors as Anti-Tumor Agents

, 4(7): 597 - 607

Gregory J. Atkins, James W. P. Smyth, Marina N. Fleeton, Sareen E. Galbraith and Brian J. Sheahan


DOI: 10.2174/1568009043332754




The Life Cycle of Cutaneous T Cell Lymphoma Reveals Opportunities for Targeted Drug Therapy

, 4(7): 609 - 619

Carole L Berger and Richard Edelson


DOI: 10.2174/1568009043332808




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science